Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 6/20 | 0.53 |
| ▸ | CFD | P00746 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.45 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24675655 | 0.91 | FFAR1 (0.49) | FFAR1CFDL3MBTL1TSHRMAPK1 | |
| SCHEMBL24675865 | 0.91 | FFAR1 (0.49) | FFAR1CFDL3MBTL1TSHRMAPK1 | |
| SCHEMBL24675243 | 0.87 | PLA2G4B (0.46) | FFAR1CFDL3MBTL1MAPK1PLA2G4B | |
| Hydrochloric Acid SCHEMBL25290504 | 0.86 | PLA2G4B (0.46) | FFAR1CFDL3MBTL1MAPK1PLA2G4B | |
| SCHEMBL24675498 | 0.84 | CNR1 (0.47) | FFAR1CFDFFAR4PLA2G4B | |
| Hydrochloric Acid SCHEMBL27225814 | 0.83 | CNR1 (0.47) | FFAR1CFDFFAR4PLA2G4B | |
| SCHEMBL2936246 | 0.83 | PPARA (0.60) | FFAR1CFDMAPK1 | |
| SCHEMBL29403718 | 0.83 | PPARA (0.60) | FFAR1CFDMAPK1 | |
| SCHEMBL928209 | 0.83 | L3MBTL1 (0.62) | FFAR1L3MBTL1TSHRFFAR4 | |
| Hydrochloric Acid SCHEMBL4933711 | 0.82 | PPARA (0.58) | FFAR1CFDMAPK1LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102746214-A | Novel indoline compounds | FOURNIER LAB SA | 2012-10-24 | — | — | CN | disclosed |
| US-7872021-B2 | LXR receptor modulators | LABORATORIES FOURNIER S.A. (FR) | 2011-01-18 | — | — | US | disclosed |
| US-7465811-B2 | Indoline compounds | LABORATOIRES FOURNIER S.A. (FR) | 2008-12-16 | — | — | US | disclosed |
| US-20080119465-A1 | Novel Indoline Compounds | LABORATORIES FOURNIER S.A. (FR) | 2008-05-22 | — | — | US | disclosed |
| US-20070099960-A1 | LXR receptor modulators | LABORATOIRES FOURNIER S.A. (FR) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099960-A1 | LXR receptor modulators | NR1H2, NR1H3, PPARD | FFAR1 40/4885CFD 3907/4885L3MBTL1 3947/4885 |
| US-20080119465-A1 | Novel Indoline Compounds | GPR119, INSR, IRS1 | FFAR1 55/4885CFD 3963/4885L3MBTL1 1493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.